The effects of SBRT on the TME, including dendritic cell activation, naïve CD8+ T-cell priming, and tumor CD8+ T-cell recruitment, have been well described in multiple solid tumors [22], although no such data exist in pSCC. The gene discussed is CD8A; the disease is neoplasm.